The U.S. government awarded a $87,220 firm fixed-price purchase order to Bruker Biospin Corp for a BRUKER MINISPEC MQ20 nuclear magnetic resonance spectrometer. The contract was awarded on September 4, 2018, with an ultimate completion date of October 4, 2018, and did not utilize a small business set-aside. The place of performance is New Orleans, Louisiana. Bruker Biospin Corp, a Massachusetts-based subsidiary of Bruker Corporation specializing in advanced scientific instrumentation, particularly NMR spectrometers and related analytical equipment, was selected as the prime contractor with no identified subcontractors on this award.
The funding agency for this procurement is a civilian entity within the Southeast Area, reflecting the federal government's need for sophisticated analytical instrumentation. Bruker Biospin Corp has an established track record of supplying scientific equipment and maintenance services to federal agencies, particularly the National Institutes of Health and its component institutes. The BRUKER MINISPEC MQ20 is a benchtop NMR spectrometer used for analytical and research applications, consistent with the company's core competency in providing advanced magnetic resonance technologies to research institutions and government laboratories across the United States.